Intel and Microsoft's Remote Patient Monitoring Announcements: Are They Dual or Dueling Efforts?

Published by: IDC

Published: Nov. 21, 2008 - 7 Pages


Table of Contents

Table of Contents

In This Perspective

Situation Overview

Intel Launches Intel Health Guide, a FDA-Cleared RPM Medical Device

Microsoft Pilots HealthVault and Its Medical Device Connectivity at Cleveland Clinic

Essential Guidance

Who Will Provide the Back-End Data Monitoring?

How Interoperable Is the Device and How Easily Can Other Devices Be Connected to the Future?

Who Pays for the Device and Infrastructure?

How Will Consumers Respond to the Technology?

Future Outlook

Learn More

Related Research

Abstract

This Health Industry Insights Perspective compares and contrasts two separate announcements by Intel and Microsoft, both made on November 10, 2008, of remote patient monitoring (RPM) pilot projects each firm is conducting with leading healthcare organizations:

Intel is conducting field trials of its new Intel Health Guide (IHG), an Food and Drug Administration (FDA)-cleared medical device that connects patients with chronic conditions to their providers, at four separate healthcare organizations representing four different care management delivery models. Microsoft and the Cleveland Clinic are conducting a similar remote patient monitoring pilot study that will involve a combination of commercially available home health monitoring devices, Microsoft HealthVault and Cleveland Clinic's MyChart personal health record system.

Get full details about this report >>
 
Learn more about this product


Price and delivery options

Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.